INAB
Price
$2.19
Change
-$0.07 (-3.10%)
Updated
Aug 25 closing price
Capitalization
9.94M
SNSE
Price
$8.11
Change
+$0.15 (+1.88%)
Updated
Aug 25, 12:44 PM (EDT)
Capitalization
10.23M
Interact to see
Advertisement

INAB vs SNSE

Header iconINAB vs SNSE Comparison
Open Charts INAB vs SNSEBanner chart's image
IN8bio
Price$2.19
Change-$0.07 (-3.10%)
Volume$34.56K
Capitalization9.94M
Sensei Biotherapeutics
Price$8.11
Change+$0.15 (+1.88%)
Volume$135
Capitalization10.23M
INAB vs SNSE Comparison Chart in %
Loading...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INAB vs. SNSE commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INAB is a StrongBuy and SNSE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (INAB: $2.19 vs. SNSE: $8.11)
Brand notoriety: INAB and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INAB: 28% vs. SNSE: 43%
Market capitalization -- INAB: $9.94M vs. SNSE: $10.23M
INAB [@Biotechnology] is valued at $9.94M. SNSE’s [@Biotechnology] market capitalization is $10.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INAB’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • INAB’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than INAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INAB’s TA Score shows that 3 TA indicator(s) are bullish while SNSE’s TA Score has 5 bullish TA indicator(s).

  • INAB’s TA Score: 3 bullish, 4 bearish.
  • SNSE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SNSE is a better buy in the short-term than INAB.

Price Growth

INAB (@Biotechnology) experienced а -8.37% price change this week, while SNSE (@Biotechnology) price change was -1.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +23.43%, and the average quarterly price growth was +29.28%.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNSE($10.2M) and INAB($9.94M) have the same market capitalization . SNSE YTD gains are higher at: -18.792 vs. INAB (-71.617). INAB has higher annual earnings (EBITDA): -20.28M vs. SNSE (-26.03M). SNSE has more cash in the bank: 28.6M vs. INAB (13.2M). SNSE has less debt than INAB: SNSE (2.56M) vs INAB (3.12M). INAB (0) and SNSE (0) have equivalent revenues.
INABSNSEINAB / SNSE
Capitalization9.94M10.2M97%
EBITDA-20.28M-26.03M78%
Gain YTD-71.617-18.792381%
P/E RatioN/AN/A-
Revenue00-
Total Cash13.2M28.6M46%
Total Debt3.12M2.56M122%
TECHNICAL ANALYSIS
Technical Analysis
INABSNSE
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRBP9.890.10
+1.02%
Corbus Pharmaceuticals Holdings
DGICB14.85N/A
N/A
Donegal Group
NATL39.70-0.04
-0.10%
NCR Atleos Corp
TSN57.46-0.15
-0.26%
Tyson Foods
CSCI2.93-0.36
-10.90%
COSCIENS Biopharma Inc

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-3.10%
IDYA - INAB
47%
Loosely correlated
-1.63%
GRI - INAB
38%
Loosely correlated
+2.86%
SNSE - INAB
37%
Loosely correlated
+1.88%
CUE - INAB
33%
Poorly correlated
-0.94%
SRZN - INAB
28%
Poorly correlated
+0.09%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+5.48%
VSTM - SNSE
47%
Loosely correlated
+5.21%
ALZN - SNSE
40%
Loosely correlated
+5.96%
MOLN - SNSE
39%
Loosely correlated
+3.38%
INAB - SNSE
37%
Loosely correlated
+0.89%
GRI - SNSE
37%
Loosely correlated
+0.72%
More